Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary

Thomas W Wallace1, Jeffrey S Berger, Andrew Wang

  • 1Duke University Medical Center, Durham, NC, USA.

Insights

Elective percutaneous coronary intervention (PCI) is common in patients with systolic dysfunction. Higher risk of hospital mortality is associated with lower left ventricular ejection fraction (LVEF) after PCI.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Systolic dysfunction is common in patients undergoing elective percutaneous coronary intervention (PCI).
  • Limited data exist on the risks associated with elective PCI in patients with reduced left ventricular (LV) systolic function.

Purpose of the Study:

  • To evaluate the association between the severity of LV systolic dysfunction and hospital mortality in patients undergoing elective PCI.
  • To determine if reduced LV ejection fraction (LVEF) impacts outcomes after elective PCI.

Main Methods:

  • Retrospective cohort study of 55,709 patients undergoing elective PCI in New York State (1998-1999).
  • Patients stratified into 5 groups based on pre-PCI LVEF.
  • Multivariate analysis to calculate adjusted odds ratios (ORs) for hospital mortality.

Main Results:

  • Hospital mortality increased significantly with decreasing LVEF.
  • Adjusted OR for hospital mortality was 1.56 (95% CI 1.06-2.30) for LVEF 36-45%, 2.17 (95% CI 1.42-3.31) for LVEF 26-35%, and 3.85 (95% CI 2.46-6.01) for LVEF ≤25% compared to LVEF >55%.
  • LVEF ≤45% was associated with higher adjusted hospital mortality.

Conclusions:

  • Elective PCI is frequently performed in patients with reduced LVEF.
  • Increasingly reduced LVEF is associated with significantly higher adjusted hospital mortality after elective PCI.
  • The benefit of elective PCI versus medical therapy alone in patients with low LVEF remains unknown.

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...